Atlas Trials

The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia

Clinical trial NCT05532800 · COMPLETED

Trial details

NCT number
NCT05532800
Sponsor
Shanghai Junshi Bioscience Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hyperlipemia
Start date
2022-02-28
Primary completion
2023-02-09
Enrollment
255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.